Skip to content

JBIO JBIO Related Party Accrued Expenses And Other Current Liabilities

Related Party Accrued Expenses And Other Current Liabilities at other companies

Lightwave Logic, Inc. logo
Lightwave Logic, Inc.LWLG
$56.25K-72.0%
CrossAmerica Partners logo
CrossAmerica PartnersCAPL
$7.19M+0.1%
Alumis Inc. logo
Alumis Inc.ALMS
$12.59M-20.0%
Liberty Energy logo
Liberty EnergyLBRT
$187K+132%
Personalis, Inc. logo
Personalis, Inc.PSNL
$22.2M+10.9%
Apogee Therapeutics, Inc. logo
Apogee Therapeutics, Inc.APGE
$28.58M+7.7%

Other financials

Income statement

See full
Operating income-$43.4M-85.8%
Net income-$40.4M-5.8%
EPS (diluted)-$0.57+95.3%

Balance sheet

See full
Cash & equivalents$55.1M+24.6%
Total debt$808.0K+159%
Total equity$296.5M+455%
Total assets$319.4M+312%

Cash flow

See full
Operating cash flow-$24.1M-28.4%
CapEx$3.0K
Free cash flow-$33.7M

Valuation

See full
Market cap$1.33B+318%
Enterprise value$1.28B

Returns & leverage

See full
Return on equity-132.5%+120pp
Debt / equity
Current ratio14.3×-17.7×

Where this comes from

Reported directly by JBIO in its filing.

Tagged under the XBRL concept ck0001798749:RelatedPartyAccruedExpensesAndOtherCurrentLiabilities.

The official record: JBIO’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about JBIO's related party accrued expenses and other current liabilities.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is JBIO's related party accrued expenses and other current liabilities?
JBIO (JBIO) reported related party accrued expenses and other current liabilities of $794K in Q1 2026.
What does related party accrued expenses and other current liabilities mean?
This metric captures short-term financial obligations owed to affiliated entities, key management personnel, or major shareholders. It reflects the extent to which the company relies on related parties for operational funding or services. High balances in this category may indicate potential conflicts of interest or a reliance on non-arm's length financing arrangements.